Overview
Nikhil Huprikar is an Intensive Care Medicine provider in Columbia, Maryland. Dr. Huprikar is highly rated in 2 conditions, according to our data. His top areas of expertise are COVID-19, Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), and Eosinophilic Pneumonia.
His clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
5755 Cedar Lane, Columbia, MD 21044
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Inova Medical Group - Transplant Specialties
Oksana A. Shlobin, MD, FCCP, serves as Medical Director for the Pulmonary Hypertension Program and Director of Outreach and Education for the Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. She is also an Associate Professor of Clinical Medicine at Georgetown University School of Medicine and an Associate Clinical Professor of Medicine at the University of Virginia. Dr. Shlobin is board certified in pulmonary and critical care medicine. Dr. Shlobin has been actively involved in clinical research both during her fellowship and her tenure at Inova. She is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. Her research interests include pulmonary hypertension and interstitial lung diseases. Blog Posts What is Pulmonary Hypertension? Learn the Facts to Breathe Easy (November 2018) Pulmonary Hypertension is Serious. Learn to Spot the Signs (May 2017). Dr. Shlobin is highly rated in 19 conditions, according to our data. Her top areas of expertise are Pulmonary Hypertension, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Endoscopy.
3800 Reservoir Road Northwest PHC
Anne O Donnell is an Intensive Care Medicine provider in Washington, Washington, D.c.. Dr. O Donnell has been practicing medicine for over 44 years is highly rated in 10 conditions, according to our data. Her top areas of expertise are Bronchiectasis, Nontuberculous Mycobacterial Lung Disease, Lung Metastases, and Obstructive Sleep Apnea.
University Of Maryland Dermatologists
Khanjan Nagarsheth is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Nagarsheth is highly rated in 24 conditions, according to our data. His top areas of expertise are Arterial Embolism, Median Arcuate Ligament Syndrome (MALS), May Thurner Syndrome, Embolectomy, and Carotid Artery Surgery.
Frequently Asked Questions about Dr. Nikhil A. Huprikar
How do I make an appointment with Dr. Nikhil A. Huprikar?
You can book an appointment with Dr. Nikhil A. Huprikar by calling their office at 410-740-7890. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Nikhil A. Huprikar a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nikhil A. Huprikar is classified as an Advanced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nikhil A. Huprikar specialize in?
While Dr. Nikhil A. Huprikar is a Intensive Care Medicine, they have specific expertise in COVID-19, Long Haul COVID, and Severe Acute Respiratory Syndrome (SARS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.
Does Dr. Nikhil A. Huprikar participate in research or clinical trials?
Yes. Dr. Nikhil A. Huprikar has published 34 articles and abstracts on conditions like COVID-19. You can view a list of Dr. Nikhil A. Huprikar's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Nikhil A. Huprikar accept my insurance?
Dr. Nikhil A. Huprikar accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-740-7890 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Dr. Huprikar isAdvanced. Learn about COVID-19.
- Long Haul COVIDDr. Huprikar isAdvanced. Learn about Long Haul COVID.
- Experienced
- Chronic Eosinophilic PneumoniaDr. Huprikar isExperienced. Learn about Chronic Eosinophilic Pneumonia.
- Chronic Obstructive Pulmonary Disease (COPD)
- Collapsed LungDr. Huprikar isExperienced. Learn about Collapsed Lung.
- Eosinophilic PneumoniaDr. Huprikar isExperienced. Learn about Eosinophilic Pneumonia.
- Hypereosinophilic SyndromeDr. Huprikar isExperienced. Learn about Hypereosinophilic Syndrome.
- PneumoniaDr. Huprikar isExperienced. Learn about Pneumonia.
